| pubmed-article:16499879 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16499879 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:16499879 | lifeskim:mentions | umls-concept:C0684224 | lld:lifeskim |
| pubmed-article:16499879 | lifeskim:mentions | umls-concept:C0020663 | lld:lifeskim |
| pubmed-article:16499879 | lifeskim:mentions | umls-concept:C0003779 | lld:lifeskim |
| pubmed-article:16499879 | lifeskim:mentions | umls-concept:C0011570 | lld:lifeskim |
| pubmed-article:16499879 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
| pubmed-article:16499879 | lifeskim:mentions | umls-concept:C1515670 | lld:lifeskim |
| pubmed-article:16499879 | lifeskim:mentions | umls-concept:C0439611 | lld:lifeskim |
| pubmed-article:16499879 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:16499879 | pubmed:dateCreated | 2006-10-18 | lld:pubmed |
| pubmed-article:16499879 | pubmed:abstractText | Elevated arginine vasopressin (AVP) plasma levels have been observed in major depression, particularly in relation to the melancholic subtype. Two hypothalamic structures produce plasma vasopressin: the supraoptic nucleus (SON) and the paraventricular nucleus (PVN). The aim of this study was to establish which structure is responsible for the increased vasopressin plasma levels in depression. | lld:pubmed |
| pubmed-article:16499879 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16499879 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16499879 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16499879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16499879 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16499879 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16499879 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:16499879 | pubmed:issn | 0006-3223 | lld:pubmed |
| pubmed-article:16499879 | pubmed:author | pubmed-author:SwaabDick FDF | lld:pubmed |
| pubmed-article:16499879 | pubmed:author | pubmed-author:UnmehopaUnga... | lld:pubmed |
| pubmed-article:16499879 | pubmed:author | pubmed-author:HofmanMichel... | lld:pubmed |
| pubmed-article:16499879 | pubmed:author | pubmed-author:HoogendijkWit... | lld:pubmed |
| pubmed-article:16499879 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:16499879 | pubmed:author | pubmed-author:MeynenGerbenG | lld:pubmed |
| pubmed-article:16499879 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16499879 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:16499879 | pubmed:volume | 60 | lld:pubmed |
| pubmed-article:16499879 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16499879 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16499879 | pubmed:pagination | 892-5 | lld:pubmed |
| pubmed-article:16499879 | pubmed:meshHeading | pubmed-meshheading:16499879... | lld:pubmed |
| pubmed-article:16499879 | pubmed:meshHeading | pubmed-meshheading:16499879... | lld:pubmed |
| pubmed-article:16499879 | pubmed:meshHeading | pubmed-meshheading:16499879... | lld:pubmed |
| pubmed-article:16499879 | pubmed:meshHeading | pubmed-meshheading:16499879... | lld:pubmed |
| pubmed-article:16499879 | pubmed:meshHeading | pubmed-meshheading:16499879... | lld:pubmed |
| pubmed-article:16499879 | pubmed:meshHeading | pubmed-meshheading:16499879... | lld:pubmed |
| pubmed-article:16499879 | pubmed:meshHeading | pubmed-meshheading:16499879... | lld:pubmed |
| pubmed-article:16499879 | pubmed:meshHeading | pubmed-meshheading:16499879... | lld:pubmed |
| pubmed-article:16499879 | pubmed:meshHeading | pubmed-meshheading:16499879... | lld:pubmed |
| pubmed-article:16499879 | pubmed:meshHeading | pubmed-meshheading:16499879... | lld:pubmed |
| pubmed-article:16499879 | pubmed:meshHeading | pubmed-meshheading:16499879... | lld:pubmed |
| pubmed-article:16499879 | pubmed:meshHeading | pubmed-meshheading:16499879... | lld:pubmed |
| pubmed-article:16499879 | pubmed:meshHeading | pubmed-meshheading:16499879... | lld:pubmed |
| pubmed-article:16499879 | pubmed:meshHeading | pubmed-meshheading:16499879... | lld:pubmed |
| pubmed-article:16499879 | pubmed:meshHeading | pubmed-meshheading:16499879... | lld:pubmed |
| pubmed-article:16499879 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16499879 | pubmed:articleTitle | Increased arginine vasopressin mRNA expression in the human hypothalamus in depression: A preliminary report. | lld:pubmed |
| pubmed-article:16499879 | pubmed:affiliation | Netherlands Institute for Brain Research, Vrije Universiteit Medical Center and Geestelijke Gezondheidszorg Buitenamstel, Amsterdam, The Netherlands. g.meynen@nih.knaw.nl | lld:pubmed |
| pubmed-article:16499879 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16499879 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16499879 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16499879 | lld:pubmed |
